产品封面图

Phospho-Bcl2 (Ser87)磷酸化Bcl-2抗体

收藏
  • ¥1580
  • LMAI Bio
  • LM-12577R
  • 进口/国产
  • 2026年06月05日
  • ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 Flow-Cyt=1μg/Test ICC=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复)
  • Rabbit
  • Human, Mouse, Rat, Horse, Rabbit, 
avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 供应商

      上海联迈生物工程有限公司

    • 库存

      大量

    • 目录编号

      LM-12577R

    • 克隆性

      多克隆

    • 抗原来源

      Rabbit

    • 保质期

      1年

    • 抗体英文名

      Phospho-Bcl2 (Ser87)

    • 抗体名

      磷酸化Bcl-2抗体

    • 宿主

      Rabbit

    • 适应物种

      Human, Mouse, Rat, Horse, Rabbit, 

    • 免疫原

      KLH conjugated synthesised phosphopeptide derived from human Bcl2 around the phosphorylation site of Ser87:AL(p-S)PV 

    • 亚型

      IgG

    • 形态

      Lyophilized or Liquid

    • 应用范围

      ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 Flow-Cyt=1μg/Test ICC=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复)

    • 浓度

      1mg/ml

    • 保存条件

      Store at -20 °C

    • 规格

      100ul  

    Phospho-Bcl2 (Ser87)磷酸化Bcl-2抗体
    英文名称 Phospho-Bcl2 (Ser87)
    中文名称 磷酸化Bcl-2抗体
    别    名 Bcl2 (phospho S87); Bcl2 (phospho Ser87); p-Bcl2 (phospho S87); p-Bcl2 (Ser87); Apoptosis regulator Bcl 2; Apoptosis regulator Bcl2; AW986256; B cell CLL/lymphoma 2; B cell leukemia/lymphoma 2; B cell lymphoma 2; Bcl 2; Bcl-2; Bcl2; BCL2 protein; C430015F12Rik; D630044D05Rik; D830018M01Rik; Leukemia/lymphoma, B-cell, 2; Oncogene B-cell leukemia 2; BCL2_HUMAN; Apoptosis regulator Bcl-2.  
    规格价格 100ul/1580元 购买        大包装/询价
    说 明 书 100ul  
    产品类型 磷酸化抗体 
    研究领域 肿瘤  细胞生物  信号转导  细胞凋亡  新陈代谢  线粒体  
    抗体来源 Rabbit
    克隆类型 Polyclonal
    交叉反应 Human, Mouse, Rat, Horse, Rabbit, 
    产品应用 ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 Flow-Cyt=1μg/Test ICC=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复) 
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量 26kDa
    细胞定位 细胞核 细胞浆 细胞膜 线粒体
    性    状 Lyophilized or Liquid
    浓    度 1mg/ml
    免 疫 原 KLH conjugated synthesised phosphopeptide derived from human Bcl2 around the phosphorylation site of Ser87:AL(p-S)PV 
    亚    型 IgG
    纯化方法 affinity purified by Protein A
    储 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
    PubMed PubMed
    产品介绍 background:
    BCL2 is an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma. Two transcript variants (alpha and beta) produced by alternate splicing, differ in their C-terminal ends. BCL2 suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. It regulates cell death by controlling the mitochondrial membrane permeability. It appears to function in a feedback loop system with caspases. BCL2 inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF1). It can form homodimers, and heterodimers with BAX, BAD, BAK and BclX(L). Heterodimerization with BAX requires intact BH1 and BH2 domains, and is necessary for anti-apoptotic activity. Also interacts with APAF1, RAF1, TP53BP2, BBC3, BCL2L1 and BNIPL.

    Function:
    Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1).

    Subunit:
    Forms homodimers, and heterodimers with BAX, BAD, BAK and Bcl-X(L). Heterodimerization with BAX requires intact BH1 and BH2 motifs, and is necessary for anti-apoptotic activity. Interacts with EI24 (By similarity). Also interacts with APAF1, BBC3, BCL2L1, BNIPL, MRPL41 and TP53BP2. Binding to FKBP8 seems to target BCL2 to the mitochondria and probably interferes with the binding of BCL2 to its targets. Interacts with BAG1 in an ATP-dependent manner. Interacts with RAF1 (the 'Ser-338' and 'Ser-339' phosphorylated form). Interacts (via the BH4 domain) with EGLN3; the interaction prevents the formation of the BAX-BCL2 complex and inhibits the anti-apoptotic activity of BCL2. Interacts with G0S2; this interaction also prevents the formation of the anti-apoptotic BAX-BCL2 complex.

    Subcellular Location:
    Mitochondrion outer membrane; Single-pass membrane protein. Nucleus membrane; Single-pass membrane protein. Endoplasmic reticulum membrane; Single-pass membrane protein.

    Tissue Specificity:
    Expressed in a variety of tissues.

    Post-translational modifications:
    Phosphorylation/dephosphorylation on Ser-70 regulates anti-apoptotic activity. Growth factor-stimulated phosphorylation on Ser-70 by PKC is required for the anti-apoptosis activity and occurs during the G2/M phase of the cell cycle. In the absence of growth factors, BCL2 appears to be phosphorylated by other protein kinases such as ERKs and stress-activated kinases. Phosphorylated by MAPK8/JNK1 at Thr-69, Ser-70 and Ser-87, wich stimulates starvation-induced autophagy. Dephosphorylated by protein phosphatase 2A (PP2A). 

    DISEASE:
    Note=A chromosomal aberration involving BCL2 has been found in chronic lymphatic leukemia. Translocation t(14;18)(q32;q21) with immunoglobulin gene regions. BCL2 mutations found in non-Hodgkin lymphomas carrying the chromosomal translocation could be attributed to the Ig somatic hypermutation mechanism resulting in nucleotide transitions.

    Similarity:
    Belongs to the Bcl-2 family.
    Database links : UniProtKB/Swiss-Prot: P10415.2 (humna)
    UniProtKB/Swiss-Prot: P49950.2 (rat) UniProtKB/Swiss-Prot: P10417.3(mouse) 

    SWISS:
    P10415

    Gene ID:
    596

    Database links:

    Entrez Gene: 596 Human

    Entrez Gene: 12043 Mouse

    Entrez Gene: 24224 Rat

    Omim: 151430 Human

    SwissProt: P10415 Human

    SwissProt: P10417 Mouse

    SwissProt: P49950 Rat

    Unigene: 150749 Human

    Unigene: 257460 Mouse

    Unigene: 9996 Rat



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 
     
    产品图片 产品细节图片1
    Paraformaldehyde-fixed, paraffin embedded (rat lung); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (BCL2) Polyclonal Antibody, Unconjugated (bs-12577R) at 1:400 overnight at 4°C, followed by a conjugated secondary (sp-0023) for 20 minutes and DAB staining.
    产品细节图片2
    Blank control(blue):K562 (fixed with 2% paraformaldehyde for 10 min at 37℃). 
    Primary Antibody:Rabbit Anti-Phospho-Bcl2 (Ser87) antibody (bs-12577R,Green); Dilution: 1μg in 100 μL 1X PBS containing 0.5% BSA; 
    Isotype Control Antibody: Rabbit IgG(orange) ,used under the same conditions; 
    Secondary Antibody: Goat anti-rabbit IgG-FITC(white blue), Dilution: 1:200 in 1 X PBS containing 0.5% BSA.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    相关实验
    • 【求助】于NF-KB 激活,P65磷酸化位点是ser536还是ser276?

      伽利略 ............................... chenlydd 两者都有,蛋白磷酸化水平与其功能密切相关:检测其磷酸化水平可用抗磷酸化位点抗体检测。www.cellsignal.com公司有相应抗体出售。 P65磷酸化位点: regulates apoptosis: S536‑p regulates cell growth: S536‑p regulates cell

    • 【第87期】 前沿靶点速递:每周医学研究精选

      CaMKII被迅速招募到SHANK3相分离凝聚体中,该过程需要CaMKII自身磷酸化及SHANK3的IDR3-1亚区内RRK基序,进一步加速凝聚体融合与PSD重塑。与人类自闭症相关的SHANK3突变(InsG3680)导致部分IDR3及SAM结构域缺失,抑制液相分离功能,造成PSD重塑和AMPAR招募缺陷。该研究揭示了活动依赖性神经可塑性的全新分子机制,为自闭症及其他神经发育障碍的治疗靶点提供了新方向。 05 靶点:TLR8 应用:类风湿性关节炎的潜在

    • Using Phospho‐Motif Antibodies to Determine Kinase Substrates

      the phosphorylation site; therefore, substrate?directed, phosphorylation?state?sensitive, motif?specific (?phospho?motif?) antibodies represent powerful tools to identify novel kinase substrates and to investigate mechanisms of substrate phosphorylation

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥780
    上海圻明生物科技有限公司
    2026年05月21日询价
    ¥1980
    温州科淼生物科技有限公司
    2025年09月01日询价
    询价
    上海古朵生物科技有限公司
    2025年07月13日询价
    询价
    上海岑特生物科技有限公司
    2025年07月05日询价
    询价
    上海远慕生物科技有限公司
    2025年07月07日询价
    Phospho-Bcl2 (Ser87)磷酸化Bcl-2抗体
    ¥1580